Health Care Equipment

Zynex

US Pre-market Zynex and ZIM Stock Price Anomaly

Zynex Inc. Obtains $22.3 Million in DIP Financing

Zynex Inc Secures $22.3 Million in Temporary Financing Facility

Zynex released FY2025 9 Months Earnings on November 17 Pre-Market EST, with actual revenue of USD 62.23 M and EPS of USD -2.412

Zynex released FY2025 Q3 earnings on November 17 Pre-Market (EST), actual revenue USD 13.36 M (forecast USD 24.53 M), actual EPS USD -1.42 (forecast USD -0.16)

Zynex to Release FY2025 Q3 Earnings on November 18 Pre-Market EST, Forecast Revenue USD 24.53 M, EPS USD -0.16

Zynex released FY2025 Q2 earnings on July 31 After-Market EST, actual revenue USD 0 (forecast USD 27.38 M), actual EPS USD 0 (forecast USD -0.1966)

Zynex released FY2025 Semi-Annual earnings on July 31 After-Market EST, with actual revenue of USD 48.87 M and EPS of USD -0.9838

Zynex to release FY2025 Q2 earnings on July 31 After-Market EST, forecast revenue USD 27.38 M, EPS USD -0.1966

Zynex, Inc. Sued by Shareholders for Misleading Statements

ZYNEX Announces Steven Dyson as New CEO

Zynex, Inc. wins award in UK

Zynex Inc. Obtains Patent for Sepsis Detection Device

Zynex Inc Sees $5 Million in Annual Cost Savings from Layoffs

Deadline Approaching for Zynex, Inc. Class Action Suit

Zynex, Inc. Submits Important Document

Zynex investors urged to contact lawyer for potential losses

RBC Maintains Zynex Rating, Cuts Price Target

Zynex released FY2025 Q1 earnings on April 29 After-Market EST, actual revenue USD 26.58 M (forecast USD 30.75 M), actual EPS USD -0.33 (forecast USD -0.24)

Zynex Inc. Reports Q1 2025 Net Loss of $10.4 Million

EKSO Bionics

Antelope Enterprise

Aimei Health Tech

Profusa

Delixy

Urgently

Jyong Biotech

Cemtrex

CID Holdco

ON24

Ticker Change

代码变更

From 2025.12.24 (EST) changed to ZYXIQ

Delcath

Electromed

Abbott Laboratories

Intuitive Surgical

Boston Scientific

Stryker

IDEXX Labs

Edwards Lifesciences

Resmed

DexCom

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap